Robot-assisted radical prostatectomy with da Vinci single-port system
DOI:
https://doi.org/10.12775/JEHS.2025.77.56945Keywords
prostate cancer, Robot assisted radical prostatectomy, robotic surgery, da Vinci Surgical System, da Vinci single-port, laparoscopic prostatectomy, open prostatectomyAbstract
Introduction and purpose
Prostate cancer is the most common malignant tumor in men in Poland. In 2021, the standardized incidence rate was 48.2 cases per 100,000 people. It is diagnosed mainly in men over 60 years of age. The choice of treatment method depends on the stage of the disease, general condition and age of the patient. Treatment mainly includes surgery, radiotherapy and hormone therapy. In the case of surgical procedures, it is possible to perform prostate cancer surgery using the Da Vinci single-port surgical robot. The aim of this literature review is to describe the procedure of radical prostatectomy using the da Vinci single-port robot and to assess the effectiveness of radical prostatectomy using the da Vinci single-port robot compared to open and laparoscopic prostatectomy.
Material and methods
This review of studies was based on articles obtained from the scientific database PubMed. Key search terms included prostate cancer; robot-assisted radical prostatectomy; robotic surgery; da Vinci Surgical System; da Vinci single-port; laparoscopic prostatectomy; open prostatectomy.
Conclusions
Currently, the da Vinci single-port surgical system is playing an increasingly important role in radical prostatectomy centers. It is increasingly replacing open radical prostatectomies due to its higher treatment efficacy and fewer complications. However, no significant differences have been demonstrated compared to classical laparoscopic surgery. Further studies are also necessary to assess functional and oncological results.
References
www.mp.pl/interna/chapter/B01.X.G.2.
Sandhu S., Moore C.M., Chiong E., Beltran H., Bristow R.G., Williams S.G. Prostate cancer. Lancet. 2021;398:1075–1090. doi: 10.1016/S0140-6736(21)00950-8
Rebello RJ, Oing C., Knudsen KE, Loeb S., Johnson DC, Reiter RE, Gillessen S., Van der Kwast T., Bristow RG Rak prostaty. Nat. Rev. Dis. Primers. 2021;7:9. doi: 10.1038/s41572-020-00243-0
Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2018. CA Cancer J. Clin. 2018;68:7–30. doi: 10.3322/caac.21442
Bergh R.C.V.D., Roemeling S., Roobol M.J., Aus G., Hugosson J., Rannikko A.S., Tammela T.L., Bangma C.H., Schröder F.H. Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly. Eur. Urol. 2009;55:1–8. doi: 10.1016/j.eururo.2008.09.007
Luzzago S., Suardi N., Dell’Oglio P., Cardone G., Gandaglia G., Esposito A., De Cobelli F., Cristel G., Kinzikeeva E., Freschi M., et al. Multiparametric MRI represents an added value but not a substitute of follow-up biopsies in patients on active surveillance for low-risk prostate cancer. Eur. Urol. Suppl. 2017;16:e1395–e1396. doi: 10.1016/S1569-9056(17)30854-0
Canadian Cancer Society. Survival statistics for prostate cancer [Internet]. Toronto (ON): The Society; 2016
Wasim S, Lee SY, Kim J. Complexities of Prostate Cancer. Int J Mol Sci. 2022 Nov 17;23(22):14257. doi: 10.3390/ijms232214257. PMID: 36430730; PMCID: PMC9696501
Cancer Genome Atlas Research Network Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015;163:1011–1025. doi: 10.1016/j.cell.2015.10.025
Robinson D., Van Allen EM, Wu YM, Schultz N., Lonigro RJ, Mosquera JM, Montgomery B., Taplin ME, Pritchard CC, Attard G. et al. Integrated clinical genomics of advanced prostate cancer. Cell. 2015;162:454. doi: 10.1016/j.cell.2015.06.053
Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules. 2022 Sep 5;27(17):5730. doi: 10.3390/molecules27175730
Crawford ED, Higano CS, Shore ND, Hussain M, Petrylak DP Treatment of patients with metastatic castration-resistant prostate cancer: a comprehensive review of available therapies. J. Urol. 2015;194:1537–1547. doi: 10.1016/j.juro.2015.06.106
Jain KK Personalized medicine in cancer treatment: from drug development to clinical practice. Expert opinion. Pharmacother. 2005;6:1463–1476. doi: 10.1517/14656566.6.9.1463
Kipriyanov EA, Karnaukh PA, Vazhenin IA, Vazhenin AV Radical prostatectomy and robotic radiosurgery as treatment options for localized prostate cancer. Sib. J.Oncol. 2020;19:50–56. doi: 10.21294/1814-4861-2020-19-1-50-56
Mouraviev V., Polascik TJ Update on cryotherapy for prostate cancer in 2006. Curr. Opinion. Urol. 2006;16:152–156. doi: 10.1097/01.mou.0000193393.54598.9f
Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. JNCI J. Natl. Cancer Inst. 2000;92:1582–1592. doi: 10.1093/jnci/92.19.1582
Mellman I., Coukos G., Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480:480–489. doi: 10.1038/nature10673
Agrawal V., Ma X., Hu J.C., Barbieri C.E., Nagar H. Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the US. JAMA Netw. Open. 2020;3:e2014674. doi: 10.1001/jamanetworkopen.2020.14674
Ngu JC, Tsang CB, Koh DC. The da Vinci Xi: a review of its capabilities, versatility, and potential role in robotic colorectal surgery. Robot Surg. 2017;4:77–85
Intuitive Surgical Inc. Intuitive Annual Report 2019. Intuitive Surgical, Inc.; 2019. Accessed February 8, 2021
Health Quality Ontario. Robotic Surgical System for Radical Prostatectomy: A Health Technology Assessment. Ont Health Technol Assess Ser. 2017 Jul 7;17(11):1-172. PMID: 28744334; PMCID: PMC5515322.
Moschovas MC, Seetharam Bhat KR, Onol FF, Rogers T, Ogaya-Pinies G, Roof S, Patel VR. Single-port technique evolution and current practice in urologic procedures. Asian J Urol. 2021 Jan;8(1):100-104. doi: 10.1016/j.ajur.2020.05.003.
Li CC, Chien TM, Lee MR, Lee HY, Ke HL, Wen SC, Chou YH, Wu WJ. Extraperitoneal Robotic Laparo-Endoscopic Single-Site Plus1-Port Radical Prostatectomy Using the da Vinci Single-Site Platform. J Clin Med. 2021 Apr 8;10(8):1563. doi: 10.3390/jcm10081563
Kwang Hyun Kim, Hyun Kyu Ahn, Myong Kim, Hana Yoon,
Technique and perioperative outcomes of single-port robotic surgery using the da Vinci SP platform in urology, Asian Journal of Surgery, Volume 46, Issue 1,2023, Pages 472-477,
ISSN 1015-9584, doi.org/10.1016/j.asjsur.2022.05.128
Moschovas MC, Brady I, Noel J, Zeinab MA, Kaviani A, Kaouk J, Crivellaro S, Joseph J, Mottrie A, Patel V. Contemporary techniques of da Vinci SP radical prostatectomy: multicentric collaboration and expert opinion. Int Braz J Urol. 2022 Jul-Aug;48(4):696-705.doi: 10.1590/S1677-5538.IBJU.2022.99.16
Stephenson AJ, Scardino PT, Eastham JA et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 2006;98(10):715-717
Xu J, Dailey RK, Eggly S, Neale AV, Schwartz KL. Men's perspectives on selecting their prostate cancer treatment. J Natl Med Assoc. 2011; 103(6):468–78
Rojo MA, Martinez-Salamanca JI, Maestro MA, Galarza IS, Rodriguez JC. Impact of cosmetic result on selection of surgical treatment in patients with localized prostate cancer. JSLS. 2014 Oct-Dec;18(4):e2014.00024
Novara G, Ficarra V, Mocellin S et al. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur. Urol. 62(3),382–404 (2012)
Ficarra V, Novara G, Artibani W et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur. Urol. 55(5),1037–1063 (2009)
Hou W, Wang B, Zhou L, Li L, Li C, Yuan P, Ouyang W, Yao H, Huang J, Yao K, Wang L. Single-site multiport vs. conventional multiport robot-assisted radical prostatectomy: A propensity score matching comparative study. Front Surg. 2022 Sep 28;9:960605. doi: 10.3389/fsurg.2022.960605
Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol. (2018) 19(8):1051–60. 10.1016/S1470-2045(18)30357-7
Jones Rabun, Dobbs W. Ryan, Halgrimson R. Whitney, Vigneswaran T. Hari, Madueke Ikenna, Wilson Jessica, Abern R. Michael, Crivellaro Simone; Single port robotic radical prostatectomy with the da Vinci SP platform: a step by step approach; Jun 2020 (Vol. 27, Issue 3, Pages( 10263 - 10269). PMID: 32544051
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Marek Kurowski, Karolina Kuczapska, Anna Gliwa, Monika Ryglewicz, Dariusz Fabian, Elżbieta Leszczyńska-Knaga, Natalia Jakubczyk, Weronika Rutkowska-Kawalec, Paweł Moczydłowski, Karolina Michalczuk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 51
Number of citations: 0